Skip to content

Celcuity CELC Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Gilead Sciences logo
Gilead SciencesGILD
-$702M-188%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$37.48M-93.5%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$10.2M-17.8%
CG Oncology logo
CG OncologyCGON
$1.61M+92.2%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
-$2.13M-472%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
-$1.3M+94.4%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's change in accrued liabilities?
Celcuity (CELC) reported change in accrued liabilities of -$6.86M in Q1 2026.
How has Celcuity's change in accrued liabilities changed year-over-year?
Celcuity's change in accrued liabilities decreased by 1183.4% year-over-year, from $633K to -$6.86M.
What is the long-term trend for Celcuity's change in accrued liabilities?
Over 2 years (2022 to 2024), Celcuity's change in accrued liabilities has grown at a 101.7% compound annual growth rate (CAGR), from $3.26M to $13.26M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.